Nerandomilast, Boehringer Ingelheim’s investigational oral therapy, significantly slowed lung function decline in people with idiopathic pulmonary…
Continue ReadingTag: Nerandomilast
Nerandomilast Slows Lung Function Decline in Patients With IPF
Nerandomilast (BI 1015550; Boehringer Ingelheim), an oral phosphodiesterase 4B (PDE4B) inhibitor, significantly slowed lung function decline…
Continue Reading
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD
Nerandomilast met its primary end point of absolute change from baseline in forced vital capacity (FVC)…
Continue Reading